1/ Recently, our lab has worked with outstanding groups (
#TeamScience) to address some key questions in kidney cancer immunobiology:
Can we use machine-learning approaches to classify RCC and predict response?
@Cancer_Cell
What drives exceptional response with immunotherapies?
@NatureCancer
How do specific immune populations, like NK cells, change in advanced disease?
@ESMO_Open
How does CD8 T cell phenotype impact response to anti-PD1 treatment?
@CD_AACR
Why does chromophobe kidney cancer seemingly have lower responses to immune checkpoint inhibitors?
@JCO_ASCO
What are immunologically relevant antigen classes in RCC (specifically, ERVs)?
@CellCellPress
Can we therapeutically target tumor-specific antigens in kidney cancer?
@Nature